Drug-induced Crystalluria in Sulfamethoxazole, High Dose Ciprofloxacin and High Dose Amoxicillin

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitair Ziekenhuis Brussel

About this trial

This study examines in hospitalized patients, treated with sulfamethoxazole, high dose ciprofloxacin or high dose iv amoxicillin, the incidence of drug-induced urinary crystal formation and its association with acute kidney injury development.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Able to give informed consent without the intervention of a legal representative

Treatment with

sulfamethoxazole/trimethoprim, with minimum dose of

Disqualifiers

Unable to give informed consent without the intervention of a legal representative

No baseline renal function up to 72 hours prior to the start of antibiotic treatment available, evaluated by serum creatinine and eGFR (CKD-EPI)) for all study groups and additional serum urea for the sulfamethoxazole group.

Treatment duration < 24 hours or insufficiently long to perform one crystalluria inves-tigation as defined in the protocol

Patients treated with hemodialysis or peritoneal dialysis, anuric patients before start of antibiotic treatment

Trial design

Treatments tested in this trial

  • Crystalluria examination

Treatment groups

290 Participants
are divided into 1 treatment group